163 related articles for article (PubMed ID: 32940719)
1. Gaining insight on mitigation of rubeosis iridis by UPARANT in a mouse model associated with proliferative retinopathy.
Locri F; Pesce NA; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Bagnoli P; Kvanta A; Dal Monte M; André H
J Mol Med (Berl); 2020 Nov; 98(11):1629-1638. PubMed ID: 32940719
[TBL] [Abstract][Full Text] [Related]
2. UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.
Locri F; Dal Monte M; Aronsson M; Cammalleri M; De Rosa M; Pavone V; Kvanta A; Bagnoli P; André H
J Mol Med (Berl); 2019 Sep; 97(9):1273-1283. PubMed ID: 31243519
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy.
Dal Monte M; Rezzola S; Cammalleri M; Belleri M; Locri F; Morbidelli L; Corsini M; Paganini G; Semeraro F; Cancarini A; Rusciano D; Presta M; Bagnoli P
Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2392-407. PubMed ID: 25766585
[TBL] [Abstract][Full Text] [Related]
4. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
[TBL] [Abstract][Full Text] [Related]
5. Mitigation of human iris angiogenesis through uPAR/LRP-1 interaction antagonism in an organotypic ex vivo model.
Pesce NA; Plastino F; Reyes-Goya C; Bernd J; Pavone V; Dal Monte M; Kvanta A; Locri F; André H
FASEB J; 2024 Mar; 38(5):e23533. PubMed ID: 38451430
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms Mediating Antiangiogenic Action of the Urokinase Receptor-Derived Peptide UPARANT in Human Retinal Endothelial Cells.
Motta C; Lupo G; Rusciano D; Olivieri M; Lista L; De Rosa M; Pavone V; Anfuso CD
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5723-5735. PubMed ID: 27787560
[TBL] [Abstract][Full Text] [Related]
8. [Clinical correlation between rubeosis iridis and optic disc neovascularization (author's transl)].
Bonnet M; Jourdain M; Francoz-Taillanter N
J Fr Ophtalmol; 1981; 4(5):405-10. PubMed ID: 6171590
[TBL] [Abstract][Full Text] [Related]
9. UPARANT: a urokinase receptor-derived peptide inhibitor of VEGF-driven angiogenesis with enhanced stability and in vitro and in vivo potency.
Carriero MV; Bifulco K; Minopoli M; Lista L; Maglio O; Mele L; Di Carluccio G; De Rosa M; Pavone V
Mol Cancer Ther; 2014 May; 13(5):1092-104. PubMed ID: 24705350
[TBL] [Abstract][Full Text] [Related]
10. The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood-Retinal Barrier Leakage in a Rat Model of Diabetes.
Cammalleri M; Locri F; Marsili S; Dal Monte M; Pisano C; Mancinelli A; Lista L; Rusciano D; De Rosa M; Pavone V; Bagnoli P
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3138-3148. PubMed ID: 28632880
[TBL] [Abstract][Full Text] [Related]
11. Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System.
Cammalleri M; Dal Monte M; Locri F; Marsili S; Lista L; De Rosa M; Pavone V; Rusciano D; Bagnoli P
J Diabetes Res; 2017; 2017():2904150. PubMed ID: 29464181
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal aflibercept for rubeosis iridis secondary to proliferative diabetic retinopathy.
Weng SW; Huang TL; Su PY; Chang PY; Wang JK
Eye Sci; 2015 Dec; 30(4):201-3. PubMed ID: 27215012
[TBL] [Abstract][Full Text] [Related]
13. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-type plasminogen activator system as drug target in retinitis pigmentosa: New pre-clinical evidence in the rd10 mouse model.
Cammalleri M; Dal Monte M; Locri F; Pecci V; De Rosa M; Pavone V; Bagnoli P
J Cell Mol Med; 2019 Aug; 23(8):5176-5192. PubMed ID: 31251468
[TBL] [Abstract][Full Text] [Related]
15. Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis.
Irvine AR; Wood IS
Am J Ophthalmol; 1987 Jun; 103(6):790-7. PubMed ID: 2438938
[TBL] [Abstract][Full Text] [Related]
16. [Differences of ocular circulation in eyes with proliferative diabetic retinopathy after panretinal photocoagulation with and without rubeosis iridis].
Fujioka S; Karashima K; Saito Y
Nippon Ganka Gakkai Zasshi; 2009 Jan; 113(1):11-5. PubMed ID: 19227927
[TBL] [Abstract][Full Text] [Related]
17. Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies.
Darche M; Cossutta M; Caruana L; Houppe C; Gilles ME; Habert D; Guilloneau X; Vignaud L; Paques M; Courty J; Cascone I
FASEB J; 2020 Apr; 34(4):5851-5862. PubMed ID: 32141122
[TBL] [Abstract][Full Text] [Related]
18. SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.
Kim KL; Seo S; Kim JT; Kim J; Kim W; Yeo Y; Sung JH; Park SG; Suh W
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2120-2131. PubMed ID: 31434494
[TBL] [Abstract][Full Text] [Related]
19. The uPAR System as a Potential Therapeutic Target in the Diseased Eye.
Cammalleri M; Dal Monte M; Pavone V; De Rosa M; Rusciano D; Bagnoli P
Cells; 2019 Aug; 8(8):. PubMed ID: 31426601
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pathologic retinal neovascularization by alpha-defensins.
Economopoulou M; Bdeir K; Cines DB; Fogt F; Bdeir Y; Lubkowski J; Lu W; Preissner KT; Hammes HP; Chavakis T
Blood; 2005 Dec; 106(12):3831-8. PubMed ID: 16123222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
